Operator of a content intelligence platform designed to enable the rational design of new molecules and medicine using AI. The company develops and builds an AI platform that utilizes engagement data from clients' analytics platforms to gather intelligence and formulate predictive reports on topics, publishing times, and distribution channels, enabling users with new strategies to treat or cure diseases by targeting RNA structure.